4th July 2013
Avingtrans plc
("Avingtrans", "Group" or "the Company")
Acquisition of Exterran UK
Avingtrans plc, which designs, manufactures and supplies critical components
and associated services to the global aerospace, energy, and medical sectors,
announces that it has acquired the entire issued share capital of Exterran (UK)
Ltd. ("Exterran UK"), the UK operations of US-based Exterran for a total
consideration of £1 (the "Acquisition").
The principal activity of the acquired business, which is based in Walsall, is
the design, fabrication and installation of products for the global oil and gas
market, including equipment solutions for petroleum production, gas processing,
produced water treatment and aftermarket parts and services. The business has
traded in the UK for many years and has been a long standing customer of
Metalcraft. The business, which employs 85 people, will be integrated into the
Energy and Medical division of Avingtrans. This new part of the division will
henceforth be known as Maloney Metalcraft Ltd, to reinvigorate a previously
well-known brand name in this market sector. Its key customers include:
Petrofac, Talisman, Porvair, EDF and Shell.
The Board believes that the Acquisition complements the existing capabilities
within its energy offering and will provide cross selling opportunities. It
will also enable the Company to pitch for larger projects once the Acquisition
is fully integrated. The Board believes that the experience and capability of
the Exterran UK engineering team will provide additional expertise as
Avingtrans looks to increase its product offering and grow the division.
In the financial year ended 31 December 2012, Exterran UK reported revenue of £
16.3 million and an adjusted loss before tax of £0.5m (which includes an
adjustment for the removal of a loss making contract which was novated
following the year end). Exterran UK is being acquired with a cash balance of £
2 million, which management believes will be sufficient to fund the turnaround
of the business, and on completion is expected to have net assets of circa £1.2
million. The Company expects Exterran UK to be at least break even in the year
ending 31 May 2015 and earnings enhancing thereafter. (1).
Steve McQuillan, Chief Executive of Avingtrans commented:
"We are pleased to announce the acquisition of Exterran UK which has a strong
pedigree. This addition to the Avingtrans Group reinforces our plan to build
the business around our two core divisions; Metalcraft (Energy and Medical) and
Sigma (Aerospace) and provides scale and expertise in the attractive Energy
marketplace. We are delighted that they will be joining the Group and are
confident of our combined future success."
-ends-
Avingtrans plc Tel: 01159 499 020
Steve McQuillan, Chief Executive Officer
Stephen King, Finance Director
Numis (Nominated Advisor & Broker) Tel: 020 7260 1000
David Poutney (Corporate Broking)
Richard Thomas (Corporate Finance and Nominated Adviser)
Newgate Threadneedle(Financial PR) Tel: 020 7653 9850
Josh Royston
Heather Armstrong
1. No statement in this announcement is intended as a profit forecast or
estimate for any period and no statement in this announcement should be
interpreted to mean that earnings or earnings per ordinary share for the
Company, for the current or future financial years would necessarily match
or exceed the historical published earnings or earnings per ordinary share.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.